![Jefferson Journal of Psychiatry](/assets/md5images/ef2ad3363dd4d436bd83de2f330a7e74.gif)
Abstract
Methylphenidate and bupropion have been demonstrated as being effective adjuncts to serotonin reuptake inhibitors in the treatment of depression (1,2). The use of these medications in case of a depressed patient whose condition was resistant to several forms of monotherapy, monotherapy with "standard" augmentation and ECT. After only a partial response to fluoxetine and methylphenidate, bupropion was added, resulting in full, sustained remission.
Recommended Citation
Bobo, William M.D.
(2001)
"Methylphenidate, Bupropion, and SSRI Triple Therapy,"
Jefferson Journal of Psychiatry: Vol. 16:
Iss.
1, Article 8.
DOI: https://doi.org/10.29046/JJP.016.1.007
Available at:
https://jdc.jefferson.edu/jeffjpsychiatry/vol16/iss1/8